Compare VRT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VRT | BSX |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | 59000 |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 103.6B | 93.4B |
| IPO Year | 2018 | 2010 |
| Metric | VRT | BSX |
|---|---|---|
| Price | $258.89 | $62.44 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 19 | 21 |
| Target Price | ★ $226.88 | $104.48 |
| AVG Volume (30 Days) | 6.6M | ★ 13.9M |
| Earning Date | 04-22-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.10% | N/A |
| EPS Growth | ★ 166.41 | 55.20 |
| EPS | ★ 3.41 | 1.94 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $33.90 | $12.02 |
| Revenue Next Year | $23.35 | $10.41 |
| P/E Ratio | $76.58 | ★ $32.38 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $60.67 | $61.25 |
| 52 Week High | $282.05 | $109.50 |
| Indicator | VRT | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 27.50 |
| Support Level | $234.72 | N/A |
| Resistance Level | $265.13 | $76.77 |
| Average True Range (ATR) | 14.62 | 1.92 |
| MACD | -2.33 | -0.35 |
| Stochastic Oscillator | 54.88 | 12.20 |
Vertiv has roots tracing back to 1946 when its founder, Ralph Liebert, developed an air-cooling system for mainframe data rooms. As computers started making their way into commercial applications in 1965, Liebert developed one of the first computer room air conditioning, or CRAC, units, enabling the precise control of temperature and humidity. The firm has slowly expanded its data center portfolio through internal product development and the acquisition of thermal and power management products like condensers, busways, and switches. Vertiv has global operations today; its products can be found in data centers in most regions throughout the world.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.